Incidence of bone pain in patients with breast cancer treated with lipegfilgrastim or pegfilgrastim: an integrated analysis from phase II and III studies-Reference-Cited by-同舟云学术

Incidence of bone pain in patients with breast cancer treated with lipegfilgrastim or pegfilgrastim: an integrated analysis from phase II and III studies

Published:2015-05-30 Issue:1 Volume:24 Page:267-273
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Bondarenko I. M.,Bias P.,Buchner A.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-015-2777-7.pdf

Reference26 articles.

1. Cooper KL, Madan J, Whyte S, Stevenson MD, Akehurst RL (2011) Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis. BMC Cancer 11:404. doi: 10.1186/1471-2407-11-404

2. Crawford J, Caserta C, Roila F (2010) Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications. Ann Oncol 21(suppl 5):v248–v251. doi: 10.1093/annonc/mdq195

3. Aapro MS, Bohlius J, Cameron DA et al (2011) 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer 47:8–32. doi: 10.1016/j.ejca.2010.10.013

4. (2014) NCCN Clinical Practice Guidelines in Oncology. Myeloid growth factors v.2.2014. National Comprehensive Cancer Network. www.nccn.org/professionals/physician_gls/f_guidelines.asp . Accessed 23 January 2015

5. Smith TJ, Khatcheressian J, Lyman GH et al (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24:3187–3205. doi: 10.1200/JCO.2006.06.4451

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multinational, drug utilization study of lipegfilgrastim use in real-world setting in Europe;Supportive Care in Cancer;2022-08-31

2. Advances in the pharmacological management of neutropenia in solid tumors: the advent of biosimilars;Expert Opinion on Pharmacotherapy;2021-02-12

3. Taxane-induced pain in breast cancer patients as perceived by nurses;Acta Oncologica;2021-02-10

4. Efficacy and Safety of Lipegfilgrastim in Lung Cancer Patients Receiving Myelosuppressive Chemotherapy in a Real-World Setting: Results of an Analysis of Pooled Data from Two Non-Interventional European Studies;Oncology Research and Treatment;2021-01-21

5. Does bevacizumab increase joint pain in patients with cancer? Results of the prospective observational BEVARTHRALGIA study;Cancer Chemotherapy and Pharmacology;2021-01-12